October 13, 2020
CMS halts COVID-19 testing in non-CLIA-certified labs
Editor's Note
The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification.
The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19 without CLIA certifications in place or performing COVID-19 testing outside the scope of existing CLIA certifications.
Free Daily News
- Governors form alliance to fill federal public health gaps amid cuts, shutdown
- UnitedHealthcare anesthesia cuts spark backlash over patient access risks
- Your playbook for OR wins is in Anaheim
- UCSF surgeons spotlight innovation, perioperative research at national surgical conference
- FDA recalls affect surgical staplers, OR procedure kits, ultrasound systems used in hospitals
- C-sections linked to longer recovery, higher pain, sleep problems for new mothers
- AI model grades nursing procedures with near-human precision
- Study: Hospitals can safely cut low-value preop tests before routine surgeries
- New studies highlight opportunities to improve pediatric anesthesia safety, comfort
- Social and behavioral factors emerging as key predictors of recovery quality after surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement